病毒检测试剂盒市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按测试类型、按应用、最终用户、地区和竞争细分

2022年，全球病毒检测试剂盒市场估值达到148.4亿美元，预计在预测期内大幅成长，预计年复合成长率（CAGR）为5.55%，到2028年预计将达到204.3亿美元。检测试剂盒是重要的诊断工具，用于透过各种检测方法（包括DFA、凝集检测、PCR 和固相检测）检测感染者体内的抗体。病毒逐渐影响淋巴球，而淋巴球在人体的免疫防御中扮演至关重要的角色。先进的技术平台，例如用于核酸视觉识别的酶辅助奈米复合物，可以设计用于检测多种疾病。这些试剂盒有助于控制新兴传染病和高流行感染。它们是基于病毒学实验室常用的快速抗原检测、血清学和分子诊断技术来检测病毒抗体。

主要市场驱动因素

1. 传染病日益流行

市场概况
预测期	2024-2028
2022 年市场规模	148.4亿美元
2028 年市场规模	204.3亿美元
2023-2028 年CAGR	5.55%
成长最快的细分市场	肝炎
最大的市场	北美洲

全球罕见疾病负担日益增加，需要对各种慢性病进行准确的诊断和有效的治疗策略。由于对末期疾病症状的认识提高，中国、印度、日本、巴西和其他东南亚国家等发展中国家的诊断率有所提高。然而，即使拥有技术先进的诊断设备，微小的人为错误仍然会阻碍这一过程，导致大量患者在早期阶段未被诊断出来，并使治疗变得复杂。流感流行和大流行对个人和人群都有深远的影响。流感的负担因年龄和基本健康状况而异，高风险患者，如老年人和已有疾病的患者，会更频繁地住院和护理。随着患者人数持续增长，评估流感负担的需求日益增加，特别是由于医疗费用不断上涨。然而，要准确估计疾病盛行率可能具有挑战性，因为流感经常被误认为是其他病毒性疾病，导致漏报。除了与医疗相关的直接成本（例如缺勤和工作效率损失）之外，流感的间接成本也相当可观。法国、美国和德国的成本估算表明，间接成本可能比直接成本高出五到十倍。因此，了解流感的真正负担对于有效的资源分配和缓解策略至关重要。

2. 早期诊断意识的提高

人们对早期诊断的认识不断提高，在增加病毒检测试剂盒的需求方面发挥重要作用。早期诊断对于有效的疾病管理、疫情控制和公共卫生干预至关重要。随着人们对及时检测重要性的认识不断增强，对病毒检测试剂盒的需求预计将会增加。早期诊断可以及时进行医疗干预，从而获得更好的治疗结果，并有可能预防疾病进展或併发症。对于传染病，例如病毒爆发，早期诊断有助于及时识别和隔离感染者，减少病毒在社区内的传播。快速检测和早期诊断使感染者能够采取适当的预防措施，防止将病毒传播给其他人，从而为整体公共卫生工作做出贡献。早期诊断有助于识别和通知感染者的密切接触者，促进有效的接触者追踪和遏制策略。及时诊断使医疗保健系统能够有效地分配资源，包括病床、医疗用品和医护人员。

3. 快速检测疾病的需求不断成长

对疾病快速检测的需求不断增长是推动病毒检测试剂盒需求增加的关键因素。快速、准确的疾病检测对于及时介入、有效治疗和公共卫生遏制工作至关重要。快速检测可以及早开始适当的治疗，从而改善患者的治疗结果，并有可能预防疾病进展或併发症。对于传染病，快速检测有助于快速识别和隔离感染者，最大限度地减少疾病在社区内传播的可能性，并减少疫情爆发的整体影响。快速检测能够及时追踪接触者并通知与感染者有过密切接触的人，有助于防止进一步传播。快速检测在医疗机构等高风险环境中至关重要，快速识别感染可以防止疾病在患者和医护人员之间传播。公共卫生意识、全球旅行、新出现的疾病和技术进步等因素的融合使人们越来越认识到快速检测疾病的必要性。这种认识反过来又推动了对病毒检测试剂盒的需求增加，这些试剂盒可以提供快速、准确的结果，从而能够及时应对各种疾病威胁。

4. 新型病毒检测试剂盒介绍

新型病毒检测试剂盒的推出是病毒检测试剂盒需求增加的重要动力。这些新颖的试剂盒通常带来技术、便利性、准确性、速度和可及性方面的进步，从而提高了人们对各种传染病检测的兴趣。新型检测试剂盒通常利用创新技术来提高病毒检测的敏感度和特异性，减少假阴性或假阳性的可能性。与可能需要更长时间的传统测试方法相比，许多新的测试套件可以快速提供结果，有时只需几分钟或几小时。这种速度对于及时诊断和疾病管理至关重要。一些新颖的检测套件专为即时护理使用而设计，使得检测能够在传统医疗环境之外进行。这种可访问性扩大了测试范围和便利性。新颖的检测套件通常旨在易于使用，使其适合更广泛的医疗保健专业人员和环境。这可能会导致测试采用率的提高。家庭测试套件的推出使个人能够在舒适的家中进行自我测试，从而提高了测试的可用性和隐私性。新型病毒检测试剂盒的推出满足了对准确、方便和快速检测解决方案日益增长的需求。随着技术的不断发展和医疗保健需求的发展，这些进步有助于更广泛地采用检测实践并更加重视疾病检测和遏制。

主要市场挑战

1. LMIC（低收入和中等收入国家）经济体缺乏认识

由于病毒诊断产品的生命週期较短以及监管审批方法的变化，诊断领域与製药业的其他领域有所不同。在政府改善医疗设施和不断增加的患者人数的推动下，诊断市场正在经历成长，特别是在新兴国家。然而，与已开发经济体相比，新兴经济体获得诊断测试的机会有限仍然是一个挑战。由于识字率低、缺乏网路连线和医疗基础设施有限等挑战，中低收入国家经济体获得可靠资讯的机会往往有限。这导致人们对病毒检测的重要性和检测试剂盒的可用性缺乏认识。许多中低收入国家在向其人民提供充分的健康教育方面面临挑战。因此，个人可能无法完全理解及时检测传染病的重要性。

2. 复杂的监管环境阻碍市场成长

严格而复杂的监管要求可能会导致新病毒检测试剂盒批准的延迟。这可能会减慢创新和改进的测试技术推向市场的速度。满足复杂的监管标准通常需要在研究、测试、文件和品质保证流程方面进行大量投资。这会增加测试套件的开发和製造成本。由于克服监管障碍带来的挑战，复杂的法规可能会阻碍製造商投资研发。不同的国家或地区可能有不同的监管要求，这给想要在国际上分销其检测套件的製造商带来了挑战。这可能会阻碍市场扩张。较小的製造商或新创公司可能会发现很难通过复杂的监管流程，从而为进入市场设置障碍。这会限制竞争和创新。不同类型的病毒检测试剂盒（例如诊断、筛检、监测）可能面临不同的监管途径，为提供多种产品的製造商带来复杂性。

主要市场趋势

1. 新兴经济体提供丰厚的成长机会

印度、巴西和中国等新兴经济体为私人医疗部门提供了利润丰厚的机会。跨国公司透过合作或收购当地诊断公司在这些国家建立了自己的业务。在印度、中国和巴西等发展中国家，生活水准的提高和人口老化推动了对慢性病诊断和管理的需求，疾病负担正在转变。新兴经济体为私营卫生部门提供了巨大的成长潜力。中产阶级的崛起、城市化进程的加速以及可支配收入的成长正在推动对品质医疗服务的更高需求，包括慢性病的诊断、治疗和管理。许多跨国医疗保健公司认识到这些市场的机会，并透过策略伙伴关係、合作、收购或投资当地诊断公司来建立自己的影响力。这使他们能够利用当地的专业知识和基础设施，同时扩大其全球足迹。与当地诊断公司合作或收购当地诊断公司可以让跨国公司了解当地市场动态、监管框架和患者需求。这使他们能够有效地定制产品并应对监管挑战。这些因素共同为病毒诊断试剂盒製造商带来了光明的成长前景。

2. 移动测试装置

配备检测设施的行动检测单元可以到达偏远和服务不足的地区，提高检测的可及性和覆盖范围。移动侦测装置可以克服地理障碍，到达远离医疗机构的地区。这确保了生活在偏远地区的个人无需长途跋涉即可获得检测服务。缺乏交通基础设施可能是获得医疗服务的主要障碍。行动装置消除了个人出行的需要，使测试变得更加方便和容易。移动检测单位可以专门针对服务不足的社区，这些社区可能缺乏适当的医疗设施。这种方法有助于缩小医疗保健差距，并确保每个人都有机会接受检测。

细分市场洞察

测试类型见解

根据测试类型，市场分为 DFA 测试、侧流测试、RT-PCR、凝集测定、固相测定等。 DFA 测试由于使用萤光标记抗体来检测特定病毒抗原的存在而占据了市场主导地位。它们已用于诊断某些病毒，例如流感等呼吸道病毒和呼吸道合胞病毒（RSV），这些病毒在人群中普遍流行。此外，RT-PCR 是市场上快速成长的领域，因为透过聚合酶炼式反应 (PCR) 检测广泛使用核酸检测。寡核苷酸合成、核酸萃取标准化自动化程序以及 PCR 产物即时检测的进步进一步支持了这一点，预计未来几年将增加对 RT-PCR 的需求。

最终使用者见解

根据最终用户，市场分为医院和诊所、诊断中心和实验室、学术和研究机构等。医院和诊所是个人寻求医疗协助的主要医疗机构。这些设置执行各种类型的病毒测试来诊断感染并指导患者治疗，这就是为什么医院和诊所部门预计将在预测期内主导市场的原因。

区域洞察

在试剂盒製造公司对研发的大量投资以及众多检测实验室和医院的建立的推动下，北美是病毒检测诊断试剂盒市场的主导力量。该地区对病毒检测诊断试剂盒的需求不断增长，特别是由于寨卡病毒感染的流行，推动了整个预测期内市场的成长。此外，创新检测试剂盒的推出以及有关产品製造的有利政府法规预计将为北美病毒诊断检测试剂盒市场提供强劲的成长平台。

目录

第 1 章：产品概述

• 市场定义
• 市场范围
  • 涵盖的市场
  • 考虑学习的年份
  • 主要市场区隔

第 2 章：研究方法

• 研究目的
• 基线方法
• 主要产业伙伴
• 主要协会和二手资料来源
• 预测方法
• 数据三角测量与验证
• 假设和限制

第 3 章：执行摘要

• 市场概况
• 主要市场细分概述
• 主要市场参与者概述
• 重点地区/国家概况
• 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球病毒检测试剂盒市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依测试类型（DFA 测试、侧流层析测试、RT-PCR、凝集测定、固相测定等）
  • 按应用（流感、肝炎、爱滋病毒、麻疹/风疹、轮状病毒、其他）
  • 按最终使用者（医院和诊所、诊断中心和实验室、学术和研究机构、其他）
  • 按地区
  • 按公司划分 (2022)
• 市场地图

第 6 章：北美病毒检测试剂盒市场前景

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按测试类型
  • 按应用
  • 按最终用户
  • 按国家/地区
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲病毒检测试剂盒市场前景

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按测试类型
  • 按应用
  • 按最终用户
  • 按国家/地区
• 欧洲：国家分析
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区病毒检测试剂盒市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按测试类型
  • 按应用
  • 按最终用户
  • 按国家/地区
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲病毒检测试剂盒市场前景

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按测试类型
  • 按应用
  • 按最终用户
  • 按国家/地区
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲病毒检测试剂盒市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按测试类型
  • 按应用
  • 按最终用户
  • 按国家/地区
• MEA：国家分析
  • 南非病毒检测套件
  • 沙乌地阿拉伯病毒检测试剂盒
  • 阿联酋病毒检测试剂盒

第 11 章：市场动态

• 司机
• 挑战

第 12 章：市场趋势与发展

• 近期发展
• 併购
• 产品发布

第 13 章：全球病毒检测试剂盒市场：SWOT 分析

第 14 章：波特的五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 客户的力量
• 替代产品的威胁

第15章：竞争格局

• 商业概览
• 服务内容
• 最近的发展
• 主要人员
• SWOT分析
  • Qiagen
  • Abbott
  • Thermo Fisher Scientific
  • Becton, Dickinson and Company
  • BioMerieux SA
  • Quidel Corporation
  • .Rapikit
  • Zoetis Inc
  • Luminex Corporation
  • F. Hoffmann-La Roche Ltd

第 16 章：策略建议

第 17 章：关于我们与免责声明

The Global Virus Testing Kits Market reached a valuation of USD 14.84 Billion in 2022 and is poised for substantial growth in the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 5.55% and expected to reach USD 20.43 Billion through 2028. Virus testing kits serve as vital diagnostic tools used to detect antibodies in infected individuals through various testing methods, including DFA, agglutinating testing, PCR, and solid-stage testing. Viruses progressively affect lymphocytes, which play a crucial role in the body's immune defense. Advanced technology platforms, such as enzyme-assisted nano complexes for visual identification of nucleic acids, can be designed to detect a wide range of diseases. These kits are instrumental in controlling emerging infectious diseases and high-prevalence infections. They are based on techniques commonly employed in virology laboratories for rapid antigen testing, serology, and molecular diagnostics to detect virus antibodies.

Key Market Drivers

1. Growing Prevalence of Infectious Diseases

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 14.84 Billion
Market Size 2028	USD 20.43 Billion
CAGR 2023-2028	5.55%
Fastest Growing Segment	Hepatitis
Largest Market	North America

The increasing global burden of rare diseases necessitates accurate diagnosis and effective treatment strategies for various chronic conditions. Developing countries such as China, India, Japan, Brazil, and other Southeast Asian nations have witnessed improved diagnosis rates due to heightened awareness of terminal illness symptoms. However, even with technologically advanced diagnostic equipment, a small margin of human error still hinders the process, resulting in a significant number of patients remaining undiagnosed at an early stage and complicating treatment. Influenza epidemics and pandemics have a profound impact on both individuals and populations. The burden of influenza varies depending on age and underlying health conditions, with high-risk patients, such as the elderly and those with pre-existing medical conditions, experiencing more frequent hospitalizations and care. As patient populations continue to grow, there is an increasing need to assess the burden of influenza, particularly due to escalating medical costs. However, accurately estimating disease prevalence can be challenging, as influenza is often mistaken for other viral illnesses, leading to under-reporting. In addition to direct costs associated with medical care, such as absenteeism and loss of work efficiency, indirect costs of influenza are substantial. Cost estimates from France, the United States, and Germany have shown that indirect costs can be five to ten times higher than direct costs. Thus, understanding the true burden of influenza is crucial for effective resource allocation and mitigation strategies.

2. Rising Awareness Regarding Early Diagnosis

Rising awareness regarding early diagnosis plays a significant role in increasing the demand for virus testing kits. Early diagnosis is crucial for effective disease management, outbreak control, and public health interventions. As awareness about the importance of timely testing grows, the demand for virus testing kits is expected to rise. Early diagnosis allows for timely medical intervention, which can lead to better treatment outcomes and potentially prevent disease progression or complications. In the case of infectious diseases, such as viral outbreaks, early diagnosis helps identify and isolate infected individuals promptly, reducing the spread of the virus within communities. Rapid testing and early diagnosis enable infected individuals to take appropriate precautions to prevent transmitting the virus to others, contributing to overall public health efforts. Early diagnosis aids in identifying and notifying close contacts of infected individuals, facilitating effective contact tracing and containment strategies. Timely diagnosis allows healthcare systems to allocate resources efficiently, including hospital beds, medical supplies, and healthcare personnel.

3. Growing Need for Rapid Detection of Diseases

The growing need for rapid detection of diseases is a key factor driving the increased demand for virus testing kits. Rapid and accurate disease detection is crucial for timely intervention, effective treatment, and public health containment efforts. Rapid detection allows for early initiation of appropriate medical treatment, which can lead to improved patient outcomes and potentially prevent disease progression or complications. For infectious diseases, rapid detection helps identify and isolate infected individuals quickly, minimizing the potential spread of the disease within communities and reducing the overall impact of an outbreak. Rapid detection enables prompt contact tracing and notification of individuals who have been in close contact with infected individuals, helping to prevent further transmission. Rapid testing is crucial in high-risk environments such as healthcare settings, where quick identification of infections can prevent the spread of diseases among patients and healthcare workers. The convergence of factors such as public health awareness, global travel, emerging diseases, and technological advancements has led to a growing recognition of the need for rapid disease detection. This recognition, in turn, is driving increased demand for virus testing kits that offer quick and accurate results, enabling timely responses to various disease threats.

4. Introduction of Novel Viral Testing Kits

The introduction of novel viral testing kits is a significant driver of increased demand for virus testing kits. These novel kits often bring advancements in technology, convenience, accuracy, speed, and accessibility, leading to a heightened interest in testing for various infectious diseases. Novel testing kits often utilize innovative technologies that enhance the sensitivity and specificity of virus detection, reducing the likelihood of false negatives or false positives. Many new testing kits offer rapid results, sometimes within minutes or hours, compared to traditional testing methods that might take longer. This speed is crucial for timely diagnosis and disease management. Some novel testing kits are designed for point-of-care use, enabling testing to be conducted outside of traditional healthcare settings. This accessibility expands testing reach and convenience. Novel testing kits are often designed for ease of use, making them suitable for a broader range of healthcare professionals and settings. This can lead to increased testing adoption. The introduction of home testing kits empowers individuals to test themselves in the comfort of their homes, increasing testing availability and privacy. The introduction of novel viral testing kits aligns with the increasing demand for accurate, accessible, and rapid testing solutions. As technology continues to evolve and healthcare needs evolve, these advancements contribute to a broader adoption of testing practices and a heightened emphasis on disease detection and containment.

Key Market Challenges

1. Lack of Awareness Across LMIC (Low- and Middle-Income Countries) Economies

The field of diagnosis distinguishes itself from other sectors of the pharmaceutical industry due to a shorter life cycle for virus diagnostic products and variations in regulatory approval methods. The diagnostic market is experiencing growth, particularly in emerging countries, driven by government initiatives to improve healthcare facilities and an increasing patient population. However, limited accessibility to diagnostic tests in emerging economies remains a challenge compared to developed economies. LMIC economies often have limited access to reliable information due to challenges such as low literacy rates, lack of internet connectivity, and limited healthcare infrastructure. This results in a lack of awareness about the importance of virus testing and the availability of testing kits. Many LMICs face challenges in providing adequate health education to their populations. As a result, individuals may not fully understand the importance of timely testing for infectious diseases.

2. Complex Regulatory Scenarios to Impede Market Growth

Stringent and complex regulatory requirements can lead to delays in obtaining approvals for new virus testing kits. This can slow down the introduction of innovative and improved testing technologies to the market. Meeting complex regulatory standards often requires significant investments in research, testing, documentation, and quality assurance processes. This can increase the cost of development and manufacturing for testing kits. Complex regulations may discourage manufacturers from investing in research and development due to the challenges associated with navigating regulatory hurdles. Different countries or regions may have varying regulatory requirements, creating challenges for manufacturers aiming to distribute their testing kits internationally. This can hinder market expansion. Smaller manufacturers or startups might find it difficult to navigate complex regulatory processes, creating barriers to entering the market. This can limit competition and innovation. Different types of virus testing kits (e.g., diagnostic, screening, surveillance) might face different regulatory pathways, creating complexity for manufacturers offering multiple products.

Key Market Trends

1. Emerging Economies to Offer Lucrative Growth Opportunities

Emerging economies like India, Brazil, and China present lucrative opportunities for the private health sector. Multinational companies have established their presence in these countries through partnerships or acquisitions of local diagnostic firms. In developing nations such as India, China, and Brazil, where improving living standards and an aging population drive the demand for chronic disease diagnosis and management, the disease burden is undergoing a transformation. Emerging economies offer immense potential for growth in the private health sector. The rising middle class, increased urbanization, and growing disposable incomes are driving higher demand for quality healthcare services, including diagnostics, treatments, and management of chronic diseases. Many multinational healthcare companies recognize the opportunities in these markets and are establishing their presence through strategic partnerships, collaborations, acquisitions, or investments in local diagnostic firms. This allows them to leverage local expertise and infrastructure while expanding their global footprint. Collaborating with or acquiring local diagnostic firms provides multinational companies with an understanding of local market dynamics, regulatory frameworks, and patient needs. This enables them to tailor their offerings effectively and navigate regulatory challenges. These factors collectively contribute to the promising growth prospects for manufacturers of virus diagnostic kits.

2. Mobile Testing Units

Mobile testing units equipped with testing facilities can reach remote and underserved areas, improving testing accessibility and coverage. Mobile testing units can overcome geographical barriers by reaching areas that are far from healthcare facilities. This ensures that individuals living in remote regions have access to testing services without the need to travel long distances. Lack of transportation infrastructure can be a major obstacle to accessing healthcare services. Mobile units eliminate the need for individuals to travel, making testing more convenient and accessible. Mobile testing units can specifically target underserved communities, which may lack proper healthcare facilities. This approach helps bridge the healthcare gap and ensures that everyone has an opportunity to get tested.

Segmental Insights

Test Type Insights

Based on the test type, the market is segmented into DFA tests, lateral flow tests, RT-PCR, agglutination assays, solid-phase assays, and others. DFA tests dominated the market due to their use of fluorescently labeled antibodies to detect the presence of specific viral antigens. They have been used for diagnosing certain viruses, such as respiratory viruses like influenza and respiratory syncytial virus (RSV), which are commonly prevalent among the population. Moreover, RT-PCR is the rapidly growing segment in the market as nucleic acid detection is extensively utilized through the employment of polymerase chain reaction (PCR) assays. This is further supported by advancements in oligonucleotide synthesis, standardized automated procedures for nucleic acid extraction, and real-time detection of PCR products, which is expected to increase the demand for RT-PCR in the upcoming years.

End User Insights

Based on the end user, the market is segmented into hospitals & clinics, diagnostic centers & laboratories, academic & research institutions, and others. Hospitals and medical clinics are primary healthcare facilities where individuals seek medical attention. These settings perform various types of virus testing to diagnose infections and guide patient treatment, which is why the hospitals & clinics segment is expected to dominate the market in the forecast period.

Regional Insights

North America is a dominant force in the viral test diagnostic kits market, driven by substantial investments in research and development by kit manufacturing firms, as well as the establishment of numerous testing laboratories and hospitals. The region's growing demand for viral test diagnostic kits, particularly due to the prevalence of Zika virus infections, has contributed to its market growth throughout the forecast period. Furthermore, the introduction of innovative test kits and favorable government regulations pertaining to product manufacturing are expected to provide a robust growth platform for the viral diagnostic test kits market in North America.

Key Market Players

• Qiagen
• Abbott
• Thermo Fisher Scientific
• Becton, Dickinson and Company
• BioMerieux SA
• Quidel Corporation
• .Rapikit
• Zoetis Inc
• Luminex Corporation
• F. Hoffmann-La Roche Ltd

Report Scope:

In this report, the Global Virus Testing Kits Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Virus Testing Kits Market, By Test Type:

• DFA Tests
• Lateral Flow Tests
• RT-PCR
• Agglutination Assays
• Solid-Phase Assays
• Others

Virus Testing Kits Market, By Application:

• Influenza
• Hepatitis
• HIV
• Measles/Rubella
• Rotavirus
• Others

Virus Testing Kits Market, By End User:

• Hospitals & Clinics
• Diagnostic Centres & Laboratories
• Academic & Research Institutions
• Others

Virus Testing Kits Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Virus Testing Kits Market.

Available Customizations:

• Global Virus Testing Kits market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Virus Testing Kits Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Test Type (DFA Tests, Lateral Flow Tests, RT-PCR, Agglutination Assays, Solid-Phase Assays, Others)
  • 5.2.2. By Application (Influenza, Hepatitis, HIV, Measles/Rubella, Rotavirus, Others)
  • 5.2.3. By End User (Hospitals & Clinics, Diagnostic Centres & Laboratories, Academic & Research Institutions, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2022)
• 5.3. Market Map

6. North America Virus Testing Kits Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Test Type
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Virus Testing Kits Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Test Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Virus Testing Kits Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Test Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Virus Testing Kits Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Test Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Virus Testing Kits Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Test Type
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Virus Testing Kits Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Test Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Virus Testing Kits Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Test Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Virus Testing Kits Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Test Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. France Virus Testing Kits Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Test Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Virus Testing Kits Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Test Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Virus Testing Kits Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Test Type
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Virus Testing Kits Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Test Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Virus Testing Kits Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Test Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Virus Testing Kits Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Test Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Virus Testing Kits Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Test Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Virus Testing Kits Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Test Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Virus Testing Kits Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Test Type
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Virus Testing Kits Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Test Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Virus Testing Kits Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Test Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Virus Testing Kits Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Test Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Virus Testing Kits Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Test Type
  • 10.2.2. By Application
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Virus Testing Kits Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Test Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Virus Testing Kits Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Test Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Virus Testing Kits Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Test Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Virus Testing Kits Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Service Offerings
• 15.3. Recent Developments
• 15.4. Key Personnel
• 15.5. SWOT Analysis
  • 15.5.1. Qiagen
  • 15.5.2. Abbott
  • 15.5.3. Thermo Fisher Scientific
  • 15.5.4. Becton, Dickinson and Company
  • 15.5.5. BioMerieux SA
  • 15.5.6. Quidel Corporation
  • 15.5.7. .Rapikit
  • 15.5.8. Zoetis Inc
  • 15.5.9. Luminex Corporation
  • 15.5.10. F. Hoffmann-La Roche Ltd

16. Strategic Recommendations

17. About Us & Disclaimer